Abstract

Antigen-specific CD4+ T cell responses to Mycobacterium tuberculosis (Mtb) infection are important for host defense against tuberculosis (TB). However, Mtb-specific IFN-γ-producing T cells do not distinguish active tuberculosis (ATB) patients from individuals with asymptomatic latent Mtb infection (LTBI). We reasoned that the immune phenotype of Mtb-specific IFN-γ+CD4+ T cells could provide an indirect gauge of Mtb antigen load within individuals. We sought to identify immune markers in Mtb-specific IFN-γ+CD4+ T cells and hypothesized that expression of caspase-3 Mtb-specific CD4+ T cells would be associated with ATB. Using polychromatic flow cytometry, we evaluated the expression of caspase-3 in Mtb-specific CD4+ T cells from LTBI and ATB as well as from ATB patients undergoing anti-TB treatment. We found significantly higher frequencies of Mtb-specific caspase-3+IFN-γ+CD4+ T cells in ATB compared to LTBI. Caspase-3+IFN-γ+CD4+ T cells were also more activated compared to their caspase-3-negative counterparts. Furthermore, the frequencies of caspase-3+IFN-γ+CD4+ T cells decreased in response to anti-TB treatment. Our studies suggest that the frequencies of caspase-3-expressing antigen-specific CD4+ T cells may reflect mycobacterial burden in vivo and may be useful for distinguishing Mtb infection status along with other host biomarkers.

Highlights

  • Tuberculosis (TB) is one of the world’s major causes of illness and mortality [1] with about 10 million new cases and 2 million deaths occurring each year

  • Gating on live lymphocytes (Figure S1 in Supplementary Material), we evaluated the expression of active caspase-3 on IFN-γ+CD4+ T cells in active TB (ATB) patients and healthy subjects with latent Mtb infection (LTBI) (Table 1), after stimulating peripheral blood mononuclear cells (PBMCs) with Mycobacterium tuberculosis (Mtb)-cell wall (CW) antigens and ESAT6-CFP10 peptides pools

  • We found that caspase-3+IFN-γ+CD4+ T cells express higher levels of CD38 (75 vs 55%, p = 0.019), HLA-DR (98 vs 80%), and Ki-67 (40 vs 20%) compared to caspase-3−IFN-γ+CD4+ T cells (Figure 2) upon stimulation with Mtb-CW antigens

Read more

Summary

Introduction

Tuberculosis (TB) is one of the world’s major causes of illness and mortality [1] with about 10 million new cases and 2 million deaths occurring each year. Several studies have shown that the majority of individuals infected with Mtb mount robust antigen-specific CD4+ T cell responses involving T helper 1 (Th1) cytokines, such as IFN-γ and TNF-α, which are critical for activating macrophages and containing bacteria in the lung. We showed that compared to individuals with LTBI, PBMCs from ATB patients harbored significantly higher frequencies of Mtb-specific IFN-γ+CD4+ T cells expressing immune activation markers CD38 and HLA-DR and the intracellular proliferation marker Ki-67 [7]. These markers accurately identified ATB patients and correlated with response to anti-TB treatment [7]. Since ATB patients have higher frequencies of activated Mtb-specific CD4+ T cells compared to LTBI, we hypothesized that ATB would harbor higher frequencies of Mtb-specific CD4+ T cells expressing active caspase-3

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call